FENC logo

FENC
Fennec Pharmaceuticals Inc

1,318
Mkt Cap
$220.99M
Volume
153,754.00
52W High
$9.92
52W Low
$4.68
PE Ratio
-18.63
FENC Fundamentals
Price
$6.41
Prev Close
$6.15
Open
$6.15
50D MA
$7.73
Beta
0.94
Avg. Volume
227,348.07
EPS (Annual)
-$0.3409
P/B
6.17
Rev/Employee
$1.28M
$184.20
Loading...
Loading...
News
all
press releases
Equities Analysts Offer Predictions for TSE:FRX Q1 Earnings
Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at HC Wainwright lowered their Q1 2026 earnings estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
HC Wainwright Has Bearish Forecast for FENC Q1 Earnings
Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Analysts at HC Wainwright dropped their Q1 2026 earnings per share (EPS) estimates for shares of Adherex Technologies in a research note issued...
MarketBeat·17h ago
News Placeholder
HC Wainwright Issues Negative Forecast for FENC Earnings
Adherex Technologies Inc. (NASDAQ:FENC - Free Report) - Research analysts at HC Wainwright cut their Q3 2026 EPS estimates for shares of Adherex Technologies in a note issued to investors on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings pe...
MarketBeat·2d ago
News Placeholder
HC Wainwright Issues Negative Forecast for TSE:FRX Earnings
Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at HC Wainwright dropped their Q3 2026 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, March 30th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company...
MarketBeat·2d ago
News Placeholder
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below 50-Day Moving Average - Should You Sell?
Fennec Pharmaceuticals (TSE:FRX) Shares Pass Below 50-Day Moving Average - Here's Why...
MarketBeat·6d ago
News Placeholder
Adherex Technologies (FENC) to Release Earnings on Wednesday
Adherex Technologies (NASDAQ:FENC) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Adherex Technologies Q4 Earnings Call Highlights
Fennec Pharmaceuticals reported record commercial growth for PEDMARK during its fourth quarter and full year 2025 earnings call, highlighting expanding adoption in both new and existing accounts...
MarketBeat·9d ago
News Placeholder
Adherex Technologies (NASDAQ:FENC) Announces Earnings Results
Adherex Technologies (NASDAQ:FENC - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.18). The business had revenue of $13.78 million during the quarter, compared to analyst...
MarketBeat·9d ago
News Placeholder
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates
Adherex Technologies (FENC) delivered earnings and revenue surprises of -540.00% and -7.94%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Fennec Pharmaceuticals (FENC) to release Q4 earnings on March 24. Analysts expect EPS of $0.04 and revenue of $14.73 million. Stock gained 1.8% on Monday.read more...
Benzinga·9d ago
<
1
2
...
>

Latest FENC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.